Invesco Biotechnology & Genome ETF
PBE
PBE
68 hedge funds and large institutions have $56.9M invested in Invesco Biotechnology & Genome ETF in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 19 increasing their positions, 23 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Holders
68
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.89M | |
| 2 | +$1.71M | |
| 3 | +$906K | |
| 4 |
SG Americas Securities
New York
|
+$834K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$478K |
Top Sellers
| 1 | -$3.48M | |
| 2 | -$1.01M | |
| 3 | -$836K | |
| 4 |
NDSI
Newman Dignan & Sheerar Inc
Providence,
Rhode Island
|
-$625K |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$560K |